Opioid addiction linked to increased risk of dementia
22 May 2026
Major study finds opioid addiction raises dementia risk by 56% compared with non‑users.
Wearable GPS data expands understanding of schistosomiasis transmission
22 May 2026
Proximity to unsafe water strongly predicts schistosomiasis exposure, explaining sharp differences in infection and re‑infection across communities.
Global study of HIV variants underscores challenges for vaccine development
19 May 2026
Largest study of HIV genetic diversity shows evolving virus strains may complicate efforts to prevent and treat infections.
Professor Goylette Chami receives prestigious C.A. Wright Medal
19 May 2026
Professor Goylette Chami has received the C.A. Wright Medal in recognition of her major contributions to infectious disease epidemiology.
Major research project to identify shared vision for community cohesion
18 May 2026
A major UK‑wide initiative is launching a national listening exercise to understand what people value in community life and the communities they want.
Oxford Population Health researcher wins prize for work on alcohol and brain health
13 May 2026
Oxford Population Health researcher recognised for pioneering work exploring links between alcohol consumption and long-term brain health.
Better cognition tied to higher relapse risk after depression remission
7 May 2026
A new study challenges the idea that cognitive decline would be associated with depression relapse risk.
World’s largest study of women’s health marks 30 years of pioneering research
1 May 2026
Thirty years after its launch, the Million Women Study continues to shape evidence on HRT, cancer, ageing, and women’s health.
“Switching off” the ovaries reduces the risk of breast cancer recurrence by one-fifth in younger women
1 May 2026
Study shows suppressing ovarian function can significantly lower breast cancer recurrence risk in younger women already taking tamoxifen.
RECOVERY trial hailed as one of the two success stories of the COVID-19 pandemic
16 April 2026
The Chair of the COVID-19 Inquiry has described the RECOVERY trial’s identification of the drug dexamethasone as ‘one of the two success stories of the pandemic’.
New mental health pathway for primary school children reduces anxiety problems
9 April 2026
A new way of supporting primary age children’s mental health via schools has been shown to be highly effective in reducing anxiety problems.
New book tackles racism in medicine
8 April 2026
New Anti-Racist Medicine textbook explores racism’s impact on healthcare, research and education, and offers guidance for delivering more equitable care.
Professor Trey Ideker appointed Director of the Big Data Institute
9 March 2026
Professor Trey Ideker appointed Director of Oxford’s Big Data Institute, advancing AI-driven biomedical research and global collaboration.
New WHO Collaborating Centre to support healthy and sustainable diets
5 March 2026
A new WHO Collaborating Centre will contribute to the promotion of healthy and sustainable diets, particularly in the WHO European Region.
Oxford Population Health researchers to tackle one of cancer’s toughest challenges
4 March 2026
Oxford researchers join $25m international effort to uncover immune mechanisms that protect certain people from cancer.
Excess weight in early adulthood linked to higher risk of premature death
27 February 2026
Research published in Science Bulletin links excess weight in early adulthood to increased risk of premature death.
Largest study of vegetarian diets and cancer shows lower risks of five cancers
27 February 2026
Largest ever study finds vegetarian diets linked to lower risk of five cancers, but higher oesophageal cancer risk.
New model needed for gathering and sharing population health data following cuts to Demographic and Health Surveys
26 February 2026
Researchers call for a new, more equitable and sustainable global model for collecting and sharing population health data.
Study finds no links between cannabis use and cognitive decline or dementia in older people
25 February 2026
Study finds no links between cannabis use and cognitive decline or dementia in older adults, showing no evidence cannabis accelerates cognitive ageing.
